Optimized FC variants

USRE45992E · US · E1

Patent metadata
FieldValue
Publication numberUS-RE45992-E
Application numberUS-201014338413-A
CountryUS
Kind codeE1
Filing dateMar 19, 2010
Priority dateMar 20, 2009
Publication dateMay 3, 2016
Grant dateMay 3, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A variant of a parent polypeptide including an Fc region, which variant exhibits increased binding to FcRn as compared to the parent polypeptide and includes at least one amino acid modification in the Fc region.

First claim

Opening claim text (preview).

The invention claimed is: 1. A variant of a parent polypeptide comprising a Fc region, which variant exhibits increased binding to FcRn as compared to said parent polypeptide and comprises a combination of amino acid modifications selected from the group consisting of: N315D/A330V/N361D/A378V/N434Y, V264E/N315D/A378V/N390S/G420R/N434Y, N315D/A378V/N434Y, N315D/A330V/A378V/N434Y, N315D/K334E/A378V/N434Y, V264E/N315D/A378V, P228R/N315D/A330V/N361D/A378V/N434Y, P228R/P230S/N315D/A330V/N361D/A378V/N434Y, P228L/N315D/A330V/N361D/A378V/N434Y, P228L/P230S/N315D/A330V/N361D/A378V/N434Y, P230S/N315D/A330V/N361D/A378V/N434Y, P230T/V264E/N315D/K370R/A378V, of the Fc region, wherein the numbering of the amino acids in the Fc region is that of the EU index as in Kabat. 2. The variant according to claim 1 , wherein said variant is an antibody. 3. The variant according to claim 2 , wherein said antibody is an IgG antibody. 4. A pharmaceutical composition comprising a variant as defined in claim 1 . 5. A medicament comprising a variant according to claim 1 . 6. An isolated nucleic acid encoding a variant as defined in claim 1 . 7. A vector comprising the nucleic acid of claim 6 . 8. An isolated host cell containing the vector of claim 7 . 9. A method for producing a variant according to claim 1 , comprising culturing a host cell containing a vector comprising an isolated nucleic acid encoding said variant so that the nucleic acid is expressed. 10. A variant according to claim 1, wherein the Fc region of the parent polypeptide is SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, or SEQ ID NO: 4.

Assignees

Inventors

Classifications

  • Drugs for immunological or allergic disorders · CPC title

  • Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

  • Drugs for disorders of the blood or the extracellular fluid · CPC title

  • Immunosuppressants, e.g. drugs for graft rejection · CPC title

  • Drugs for disorders of the nervous system · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent USRE45992E cover?
A variant of a parent polypeptide including an Fc region, which variant exhibits increased binding to FcRn as compared to the parent polypeptide and includes at least one amino acid modification in the Fc region.
Who is the assignee on this patent?
Lab Francais Du Fractionnement
What technology area does this patent fall under?
Primary CPC classification C07K16/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (E1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).